Consolidated Balance Sheet - USD ($) $ in Millions		Jun. 30, 2024	Dec. 31, 2023
Assets
Cash and due from banks		$ 65,832	$ 61,192
Investment securities
Held-to-maturity (fair value $69,311 and $74,088, respectively)		81,486	84,045
Available-for-sale ($290 and $338 pledged as collateral, respectively)	[1]	79,799	69,706
Loans held for sale (including $2,550 and $2,011 of mortgage loans carried at fair value, respectively)		2,582	2,201
Loans
Total loans		376,133	373,835
Less allowance for loan losses		(7,549)	(7,379)
Net loans		368,584	366,456
Premises and equipment		3,570	3,623
Goodwill		12,476	12,489
Other intangible assets		5,757	6,084
Other assets (including $5,554 and $3,548 of trading securities at fair value pledged as collateral, respectively)	[1]	59,972	57,695
Total assets		680,058	663,491
Deposits
Noninterest-bearing		86,756	89,989
Interest-bearing (including $6,089 and $2,818 of time deposits carried at fair value, respectively)		437,029	422,323
Total deposits		523,785	512,312
Short-term borrowings		16,557	15,279
Long-term debt		52,720	51,480
Other liabilities		30,111	28,649
Total liabilities		623,173	607,720
Shareholders’ equity
Preferred stock		6,808	6,808
Common stock, $— par value per share, authorized: 4,000,000,000 shares; issued: 6/30/24 and 12/31/23—2,125,725,742 shares		21	21
Capital surplus		8,688	8,673
Retained earnings		75,231	74,026
Less cost of common stock in treasury: 6/30/24—565,238,392 shares; 12/31/23—567,732,687 shares		(24,020)	(24,126)
Accumulated other comprehensive income (loss)		(10,308)	(10,096)
Total U.S. Bancorp shareholders’ equity		56,420	55,306
Noncontrolling interests		465	465
Total equity		56,885	55,771
Total liabilities and equity		680,058	663,491
Commercial | Commercial
Loans
Total loans		135,248	131,881
Commercial | Commercial real estate
Loans
Total loans		51,887	53,455
Consumer | Residential mortgages
Loans
Total loans		117,147	115,530
Consumer | Credit card
Loans
Total loans		28,715	28,560
Consumer | Other retail
Loans
Total loans		$ 43,136	$ 44,409

[1] Includes only collateral pledged by the Company where counterparties have the right to sell or pledge the collateral.